Proton Pump Inhibitor Induced Depigmentation in Vitiligo
Author Information
Author(s): Holla Anantha Prasad, Kumar Ravinder, Parsad Davinder, Kanwar AJ
Primary Institution: Vitiligo Institute for Care and Research, Mangalore, India
Hypothesis
Can proton pump inhibitors cause depigmentation in patients with vitiligo?
Conclusion
Proton pump inhibitors may lead to depigmentation in vitiligo patients after successful treatment.
Supporting Evidence
- The patient experienced repigmentation after stopping the proton pump inhibitor.
- Previous reports indicated that other patients also experienced new depigmentation after using proton pump inhibitors.
- Proton pump inhibitors may induce apoptosis in melanocytes, potentially worsening vitiligo.
Takeaway
A woman with vitiligo lost color in her skin after taking a medication for her stomach, but her skin got better again when she stopped the medicine.
Methodology
The patient underwent autologous epidermal suspension transplantation and was monitored for changes in skin pigmentation after taking a proton pump inhibitor.
Potential Biases
Potential bias due to reliance on patient self-reporting and lack of control group.
Limitations
The study is based on a single case report, limiting generalizability.
Participant Demographics
A 24-year-old female with generalized vitiligo.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website